MTOR and cancer: Autophagy-related and cancer-related pathways were mainly enriched in low-risk patients, including regulation of autophagy, mTOR signaling pathway, renal cell carcinoma, pathways in cancer, and MAPK signaling pathway (Figure 10G), indicating that the autophagy was mainly involved in patients with low-risk ccRCC.